X-123184549-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_007325.5(GRIA3):āc.14A>Cā(p.Lys5Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000414 in 1,206,609 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000090 ( 0 hom., 0 hem., cov: 21)
Exomes š: 0.0000036 ( 0 hom. 2 hem. )
Consequence
GRIA3
NM_007325.5 missense
NM_007325.5 missense
Scores
1
5
8
Clinical Significance
Conservation
PhyloP100: 2.33
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.19359592).
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRIA3 | NM_000828.5 | c.14A>C | p.Lys5Thr | missense_variant | 1/16 | ENST00000622768.5 | NP_000819.4 | |
GRIA3 | NM_007325.5 | c.14A>C | p.Lys5Thr | missense_variant | 1/16 | ENST00000620443.2 | NP_015564.5 | |
GRIA3 | NM_001256743.2 | c.14A>C | p.Lys5Thr | missense_variant | 1/4 | NP_001243672.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000904 AC: 1AN: 110579Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32807
GnomAD3 genomes
AF:
AC:
1
AN:
110579
Hom.:
Cov.:
21
AF XY:
AC XY:
0
AN XY:
32807
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000365 AC: 4AN: 1096030Hom.: 0 Cov.: 29 AF XY: 0.00000553 AC XY: 2AN XY: 361464
GnomAD4 exome
AF:
AC:
4
AN:
1096030
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
361464
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000904 AC: 1AN: 110579Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32807
GnomAD4 genome
AF:
AC:
1
AN:
110579
Hom.:
Cov.:
21
AF XY:
AC XY:
0
AN XY:
32807
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2022 | This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 5 of the GRIA3 protein (p.Lys5Thr). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with GRIA3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1429226). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D;.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;.;.;N;N
PrimateAI
Uncertain
T
Sift4G
Pathogenic
D;T;D;T;T;T
Polyphen
0.016, 0.027
.;B;.;.;B;B
Vest4
MutPred
Loss of methylation at K5 (P = 0.0067);Loss of methylation at K5 (P = 0.0067);Loss of methylation at K5 (P = 0.0067);Loss of methylation at K5 (P = 0.0067);Loss of methylation at K5 (P = 0.0067);Loss of methylation at K5 (P = 0.0067);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at